These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17309571)

  • 41. Medications and therapeutic apheresis procedures: are we doing our best?
    Ibrahim RB; Balogun RA
    J Clin Apher; 2013 Feb; 28(1):73-7. PubMed ID: 23420597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The problem of under utilization of therapeutic hemapheresis.
    Ciavarella D; Wuest D
    Transfus Sci; 1993 Jul; 14(3):287-90. PubMed ID: 10146340
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic apheresis in Taiwan.
    Yeh JH; Chiu HC;
    Ther Apher; 2001 Dec; 5(6):513-6. PubMed ID: 11800091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefits and challenges of starting a new therapeutic apheresis service in a resource-constrained setting.
    Arogundade FA; Sanusi AA; Oguntola SO; Omotoso BA; Abdel-Rahman EM; Akinsola A; Balogun RA
    J Clin Apher; 2014 Aug; 29(4):194-8. PubMed ID: 24832211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
    Shemin D; Briggs D; Greenan M
    J Clin Apher; 2007; 22(5):270-6. PubMed ID: 17722046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apheresis in the Philippines.
    Narciso CT
    J Clin Apher; 2005 Jul; 20(2):107-12. PubMed ID: 15880365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a need for a national or a global apheresis registry?
    Stegmayr B; Korach JM; Norda R; Rock G; Fadel F
    Transfus Apher Sci; 2003 Oct; 29(2):179-85. PubMed ID: 12941358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience.
    Fernández-Fournier M; Kerguelen A; Rodríguez de Rivera FJ; Lacruz L; Jimeno S; Losantos I; Hernández-Maraver D; Puertas I; Tallon-Barranco A; Viejo A; Frank García A; Díez-Tejedor E
    Expert Rev Neurother; 2022 Oct; 22(10):897-903. PubMed ID: 36408604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic plasma exchange in neurologic disorders.
    Kes P
    Acta Med Croatica; 1997; 51(4-5):225-8. PubMed ID: 9473803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimated savings from paid telephone consultations between subspecialists and primary care physicians.
    Wegner SE; Humble CG; Feaganes J; Stiles AD
    Pediatrics; 2008 Dec; 122(6):e1136-40. PubMed ID: 19047214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of awareness of a randomized controlled trial on use of experimental therapy.
    Clark WF; Garg AX; Blake PG; Rock GA; Heidenheim AP; Sackett DL
    JAMA; 2003 Sep; 290(10):1351-5. PubMed ID: 12966127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?
    Edworthy S; Zummer M; Garner S; Boire G; Leclercq S; Bykerk V; Kraag G; Markland J; Thomas D; Thomson J; Henderson J
    J Rheumatol; 2008 Aug; 35(8):1506-12. PubMed ID: 18597407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
    Berhan Y
    Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic aphaeresis: experience in Puerto Rico.
    Morales Borges RH; Nieves GC; Martínez MR; Ramos RV; Pedraza Otero LI; Vargas CN; Pedraza GO; Jiménez JJ
    Transfus Apher Sci; 2014 Jun; 50(3):473-8. PubMed ID: 24667158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. National trends in psychotherapy by office-based psychiatrists.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2008 Aug; 65(8):962-70. PubMed ID: 18678801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thrombotic microangiopathy after kidney transplantation].
    Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
    Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experiences with the Introduction of Diagnosis Related Groups (DRG) in the Hungarian Ophthalmology].
    Lampé Z; Boncz I; Sebestyén A; Berta A
    Klin Monbl Augenheilkd; 2007 Jul; 224(7):575-9. PubMed ID: 17657691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The feminisation of Canadian medicine and its impact upon doctor productivity.
    Weizblit N; Noble J; Baerlocher MO
    Med Educ; 2009 May; 43(5):442-8. PubMed ID: 19422491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.